Search by Drug Name or NDC
NDC 00074-4382-20 Nimbex 10 mg/mL Details
Nimbex 10 mg/mL
Nimbex is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is CISATRACURIUM BESYLATE.
Product Information
NDC | 00074-4382 |
---|---|
Product ID | 0074-4382_8b56347b-c00b-40d9-a41a-c926e4b1c357 |
Associated GPIs | 74200013102035 |
GCN Sequence Number | 024613 |
GCN Sequence Number Description | cisatracurium besylate VIAL 10 MG/ML INTRAVEN |
HIC3 | S7A |
HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
GCN | 32770 |
HICL Sequence Number | 010278 |
HICL Sequence Number Description | CISATRACURIUM BESYLATE |
Brand/Generic | Brand |
Proprietary Name | Nimbex |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Cisatracurium besylate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/mL |
Substance Name | CISATRACURIUM BESYLATE |
Labeler Name | AbbVie Inc. |
Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020551 |
Listing Certified Through | 2023-12-31 |
Package
NDC 00074-4382-20 (00074438220)
NDC Package Code | 0074-4382-20 |
---|---|
Billing NDC | 00074438220 |
Package | 20 mL in 1 VIAL, SINGLE-DOSE (0074-4382-20) |
Marketing Start Date | 1995-12-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |